{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:19:15Z","timestamp":1793643555632,"version":"4.5.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T00:00:00Z","timestamp":1390089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10792-014-9901-4","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T08:53:32Z","timestamp":1390035212000},"page":"1043-1048","source":"Crossref","is-referenced-by-count":58,"title":["The efficacy of topical 0.05\u00a0% cyclosporine A in patients with dry eye disease associated with Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"34","author":[{"given":"H\u00fclya","family":"Devec\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senol","family":"Kobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,19]]},"reference":[{"key":"9901_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7326\/0003-4819-92-2-212","volume":"92","author":"M Haralampos","year":"1980","unstructured":"Haralampos M, Moutsoupolos MD (1980) Sj\u00f6gren\u2019s syndrome (sicca syndrome): current issues. Ann Intern Med 92:212\u2013226","journal-title":"Ann Intern Med"},{"key":"9901_CR2","unstructured":"Kanski JJ (1999) Keratoconjunctivitis Sicca. Disorders of the conjunctiva. Butterwotrh-Heinemann International Edition (4th), Clinical Ophthalmology 78\u201379"},{"key":"9901_CR3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","volume":"19","author":"SC Pflugfelder","year":"2000","unstructured":"Pflugfelder SC, Solomon A, Stern ME (2000) The diagnosis and management of dry eye. A twenty-five-year review. Cornea 19:644\u2013649","journal-title":"Cornea"},{"key":"9901_CR4","first-page":"503","volume":"59","author":"M Braida","year":"1986","unstructured":"Braida M, Knop J (1986) Effect of cyclosporine A on the T-effector and T-supressor cell response in contact sensitivity. Immunology 59:503\u2013507","journal-title":"Immunology"},{"key":"9901_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","volume":"7","author":"AL Taylor","year":"2005","unstructured":"Taylor AL, Watson CJE, Bradley JA (2005) Immunosupressive agents in solid organ transplantation. Mechanism of action and therapeutic efficacy. Crit Rev Oncol Hematol 7:23\u201346","journal-title":"Crit Rev Oncol Hematol"},{"key":"9901_CR6","first-page":"101","volume":"42","author":"K Tsubota","year":"2001","unstructured":"Tsubota K, Fujita H, Tadano K et al (2001) Improvement of lacrmal function by topical application of CyA in murine models of Sjogren\u2019s syndrome. Invest Ophthalmol Vis Sci 42:101\u2013110","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9901_CR7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","volume":"107","author":"D Stevenson","year":"2000","unstructured":"Stevenson D, Tauber J, Reis BL (2000) A Phase 2 study group efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate to severe dry eye disease. Ophthalmology 107:967\u2013974","journal-title":"Ophthalmology"},{"key":"9901_CR8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","volume":"120","author":"KS Kunert","year":"2002","unstructured":"Kunert KS, Tisdale AS, Gipson IK (2002) Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 120:330\u2013337","journal-title":"Arch Ophthalmol"},{"key":"9901_CR9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophtalmic emulsion in moderate to severe dry eye disease. Ophthalmology 107:631\u2013639","journal-title":"Ophthalmology"},{"key":"9901_CR10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) European study group on classification criteria for Sjogren\u2019s syndrome. Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European concensus group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"9901_CR11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0002-9394(79)90678-0","volume":"88","author":"A Shapiro","year":"1979","unstructured":"Shapiro A, Merin S (1979) Schirmer test and break-up time of tear film in normal subjects. Am J Ophtalmol 88:752\u2013757","journal-title":"Am J Ophtalmol"},{"key":"9901_CR12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ICO.0b013e31818d3846","volume":"28","author":"EK Akpek","year":"2009","unstructured":"Akpek EK, Klimava A, Thorne JE, Martin D, Lekhanont K, Ostrovsky A (2009) Evaluation of patients with dry eye for presence of underlying Sjogren\u2019s syndrome. Cornea 28:493\u2013497","journal-title":"Cornea"},{"key":"9901_CR13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00006324-199708000-00023","volume":"74","author":"MJ Doughty","year":"1997","unstructured":"Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K (1997) A patient questionnaire approach to estimating the prevelance of dry eye symtoms in patients presenting to optometric practices across Canada. Optom Vis Sci 74:624\u2013631","journal-title":"Optom Vis Sci"},{"key":"9901_CR14","unstructured":"Rhee DJ, Mark FP (1999) Keratokonjunctivitis sicca. Cornea 55\u201356"},{"key":"9901_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9394(14)71700-3","volume":"124","author":"SCG Tseng","year":"1997","unstructured":"Tseng SCG, Tsubota K (1997) Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol 124:825\u2013835","journal-title":"Am J Ophthalmol"},{"key":"9901_CR16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","volume":"321","author":"M Prummel","year":"1989","unstructured":"Prummel M, Mourits M, Berghout A (1989) Prednisone and cyclosporine in the treatment of severe Graves\u2019 ophthalmopathy. N Engl J Med 321:1353\u20131359","journal-title":"N Engl J Med"},{"key":"9901_CR17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","volume":"112","author":"R Nussenblatt","year":"1991","unstructured":"Nussenblatt R, Palestine A, Chan C et al (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 112:138\u2013146","journal-title":"Am J Ophthalmol"},{"key":"9901_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02230339","volume":"15","author":"C Georganas","year":"1996","unstructured":"Georganas C, Iokimidis D, Iatrou C et al (1996) Relapsing Wegener\u2019s granulomatosis: successful treatment with cyclosporine A. Clin Rheumatol 15:189\u2013192","journal-title":"Clin Rheumatol"},{"key":"9901_CR19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archopht.126.8.1046","volume":"126","author":"HD Perry","year":"2008","unstructured":"Perry HD, Solomon R, Donnenfeld ED et al (2008) Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch Ophthalmol 126:1046\u20131050","journal-title":"Arch Ophthalmol"},{"key":"9901_CR20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(79)92082-8","volume":"2","author":"DJ Coster","year":"1979","unstructured":"Coster DJ, Shepherd WF, Fook TC et al (1979) Prolonged survival of corneal allografts in rabbits treated with cyclosporine A. Lancet 2:688\u2013689","journal-title":"Lancet"},{"key":"9901_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3129\/i09-117","volume":"44","author":"Y Nochez","year":"2009","unstructured":"Nochez Y, Denoyer A, Pisella PJ (2009) 0.05% cyclosporine A for treatment of chronic severe ocular surface disease. Can J Ophthalmol 44:406\u2013411","journal-title":"Can J Ophthalmol"},{"key":"9901_CR22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/exer.1998.0619","volume":"68","author":"A Yoshida","year":"1999","unstructured":"Yoshida A, Fujihara T, Nakata K (1999) Cyclosporine increase tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in mice. Exp Eye Res 68:541\u2013546","journal-title":"Exp Eye Res"},{"key":"9901_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","volume":"18","author":"CA Utine","year":"2010","unstructured":"Utine CA, Akpek EK (2010) Clinical Review: topical ophthalmic use of cyclosporin A. Ocul Immunol Inflamm 18:352","journal-title":"Ocul Immunol Inflamm"},{"key":"9901_CR24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","volume":"72","author":"K Gunduz","year":"1994","unstructured":"Gunduz K, Ozdemir O (1994) Topical cyclosporine treatment of keratokonjonktivitis sicca in secondary Sjogren\u2019s syndrome. Acta Ophthalmol 72:438\u2013442","journal-title":"Acta Ophthalmol"},{"key":"9901_CR25","unstructured":"Toker E, Acar N, Kazoko\u011flu H (2003) Sj\u00f6gren sendromuna ba\u011fl\u0131 kuru g\u00f6z hastal\u0131\u011f\u0131nda %0.1 siklosporin A tedavisinin etkinli\u011fi. T\u00fcrk Oftalmoloji Gazetesi 33:324\u2013330"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-014-9901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-014-9901-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-014-9901-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T20:30:33Z","timestamp":1559248233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-014-9901-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,19]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["9901"],"URL":"https:\/\/doi.org\/10.1007\/s10792-014-9901-4","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,19]]}}}